APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Endostatin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Human Endostatin Market Analysis and Forecast 2026-2032

26 December 2025191 pages

Choose your research edition.

Industry ResearchRecombinant Human Endostatin Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Endostatin Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Recombinant Human Endostatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Endostatin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Endostatin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Recombinant Human Endostatin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human Endostatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Human Endostatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Human Endostatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Human Endostatin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Human Endostatin include Thermo Fisher Scientific and PeproTech etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Human Endostatin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Human Endostatin, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Human Endostatin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Endostatin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Human Endostatin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Human Endostatin sales, projected growth trends, production technology, application and end-user industry.

Recombinant Human Endostatin Segment by Company

Thermo Fisher Scientific

PeproTech

Recombinant Human Endostatin Segment by Type

Purity:95%

Others

Recombinant Human Endostatin Segment by Application

Medical Care

Scientific Research

Others

Recombinant Human Endostatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Endostatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Endostatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Endostatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Human Endostatin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Human Endostatin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Endostatin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Human Endostatin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity:95% Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global Recombinant Human Endostatin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Care Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Others Major Manufacturers Table 8. Recombinant Human Endostatin Industry Trends Table 9. Recombinant Human Endostatin Industry Drivers Table 10. Recombinant Human Endostatin Industry Opportunities and Challenges Table 11. Recombinant Human Endostatin Industry Restraints Table 12. Global Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Recombinant Human Endostatin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Recombinant Human Endostatin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Recombinant Human Endostatin Revenue Market Share by Region (2021-2026) Table 16. Global Recombinant Human Endostatin Revenue Market Share by Region (2027-2032) Table 17. Global Recombinant Human Endostatin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Recombinant Human Endostatin Sales by Region (2021-2026) & (K Units) Table 19. Global Recombinant Human Endostatin Sales by Region (2027-2032) & (K Units) Table 20. Global Recombinant Human Endostatin Sales Market Share by Region (2021-2026) Table 21. Global Recombinant Human Endostatin Sales Market Share by Region (2027-2032) Table 22. Global Recombinant Human Endostatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Recombinant Human Endostatin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Recombinant Human Endostatin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Recombinant Human Endostatin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Recombinant Human Endostatin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Recombinant Human Endostatin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Recombinant Human Endostatin Manufacturers, Product Type & Application Table 30. Global Recombinant Human Endostatin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Recombinant Human Endostatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Recombinant Human Endostatin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Recombinant Human Endostatin Revenue Market Share by Type (2021-2026) Table 37. Global Recombinant Human Endostatin Revenue Market Share by Type (2027-2032) Table 38. Global Recombinant Human Endostatin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 40. Global Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 41. Global Recombinant Human Endostatin Sales Market Share by Type (2021-2026) Table 42. Global Recombinant Human Endostatin Sales Market Share by Type (2027-2032) Table 43. Global Recombinant Human Endostatin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Recombinant Human Endostatin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Recombinant Human Endostatin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Recombinant Human Endostatin Revenue Market Share by Application (2021-2026) Table 49. Global Recombinant Human Endostatin Revenue Market Share by Application (2027-2032) Table 50. Global Recombinant Human Endostatin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 52. Global Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 53. Global Recombinant Human Endostatin Sales Market Share by Application (2021-2026) Table 54. Global Recombinant Human Endostatin Sales Market Share by Application (2027-2032) Table 55. Global Recombinant Human Endostatin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Recombinant Human Endostatin Price by Application (2027-2032) & (US$/Unit) Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. PeproTech Company Information Table 63. PeproTech Business Overview Table 64. PeproTech Recombinant Human Endostatin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. PeproTech Recombinant Human Endostatin Product Portfolio Table 66. PeproTech Recent Development Table 67. North America Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 70. North America Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 71. North America Recombinant Human Endostatin Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Recombinant Human Endostatin Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 76. North America Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 77. North America Recombinant Human Endostatin Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Recombinant Human Endostatin Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Recombinant Human Endostatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Recombinant Human Endostatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 84. North America Recombinant Human Endostatin Sales by Country (2027-2032) & (K Units) Table 85. North America Recombinant Human Endostatin Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Recombinant Human Endostatin Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 88. Canada Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 89. Mexico Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 90. Europe Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 93. Europe Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 94. Europe Recombinant Human Endostatin Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Recombinant Human Endostatin Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 99. Europe Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 100. Europe Recombinant Human Endostatin Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Recombinant Human Endostatin Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Recombinant Human Endostatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Recombinant Human Endostatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 107. Europe Recombinant Human Endostatin Sales by Country (2027-2032) & (K Units) Table 108. Europe Recombinant Human Endostatin Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Recombinant Human Endostatin Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 111. France Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 112. U.K. Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 113. Italy Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 114. Russia Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 115. Spain Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 118. Sweden Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 119. Poland Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 120. China Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 121. China Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 122. China Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 123. China Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 124. China Recombinant Human Endostatin Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Recombinant Human Endostatin Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 127. China Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 128. China Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 129. China Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 130. China Recombinant Human Endostatin Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Recombinant Human Endostatin Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 135. Asia Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 136. Asia Recombinant Human Endostatin Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Recombinant Human Endostatin Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 141. Asia Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 142. Asia Recombinant Human Endostatin Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Recombinant Human Endostatin Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Recombinant Human Endostatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Recombinant Human Endostatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 149. Asia Recombinant Human Endostatin Sales by Country (2027-2032) & (K Units) Table 150. Asia Recombinant Human Endostatin Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Recombinant Human Endostatin Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 153. South Korea Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 154. India Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 155. Australia Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Recombinant Human Endostatin Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Recombinant Human Endostatin Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Recombinant Human Endostatin Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Recombinant Human Endostatin Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Recombinant Human Endostatin Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Recombinant Human Endostatin Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Recombinant Human Endostatin Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Recombinant Human Endostatin Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Recombinant Human Endostatin Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Recombinant Human Endostatin Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Recombinant Human Endostatin Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Recombinant Human Endostatin Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Recombinant Human Endostatin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Recombinant Human Endostatin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Recombinant Human Endostatin Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Recombinant Human Endostatin Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Recombinant Human Endostatin Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Recombinant Human Endostatin Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 179. Argentina Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 180. Chile Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 181. Colombia Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 182. Peru Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 184. Israel Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 185. UAE Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 186. Turkey Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 187. Iran Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 188. Egypt Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Recombinant Human Endostatin Distributors List Table 192. Recombinant Human Endostatin Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Recombinant Human Endostatin Image Figure 2. Global Recombinant Human Endostatin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Endostatin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Purity:95% Image Figure 5. Others Image Figure 6. Global Recombinant Human Endostatin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Recombinant Human Endostatin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Care Image Figure 9. Scientific Research Image Figure 10. Others Image Figure 11. Global Recombinant Human Endostatin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Recombinant Human Endostatin Revenue (2021-2032) & (US$ Million) Figure 13. Global Recombinant Human Endostatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Recombinant Human Endostatin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Recombinant Human Endostatin Revenue Market Share by Region (2021-2032) Figure 16. Global Recombinant Human Endostatin Sales (2021-2032) & (K Units) Figure 17. Global Recombinant Human Endostatin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Recombinant Human Endostatin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Recombinant Human Endostatin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Recombinant Human Endostatin Sales YoY (2021-2032) & (K Units) Figure 21. China Recombinant Human Endostatin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Recombinant Human Endostatin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Recombinant Human Endostatin Sales YoY (2021-2032) & (K Units) Figure 24. Global Recombinant Human Endostatin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Recombinant Human Endostatin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Recombinant Human Endostatin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Recombinant Human Endostatin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Recombinant Human Endostatin Revenue Market Share by Type (2021-2032) Figure 30. Global Recombinant Human Endostatin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Recombinant Human Endostatin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Recombinant Human Endostatin Sales Market Share by Type (2021-2032) Figure 33. Global Recombinant Human Endostatin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Recombinant Human Endostatin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Recombinant Human Endostatin Revenue Market Share by Application (2021-2032) Figure 36. Global Recombinant Human Endostatin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Recombinant Human Endostatin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Recombinant Human Endostatin Sales Market Share by Application (2021-2032) Figure 39. North America Recombinant Human Endostatin Revenue Share by Type (2021-2032) Figure 40. North America Recombinant Human Endostatin Sales Share by Type (2021-2032) Figure 41. North America Recombinant Human Endostatin Revenue Share by Application (2021-2032) Figure 42. North America Recombinant Human Endostatin Sales Share by Application (2021-2032) Figure 43. North America Recombinant Human Endostatin Revenue Share by Country (2021-2032) Figure 44. North America Recombinant Human Endostatin Sales Share by Country (2021-2032) Figure 45. Europe Recombinant Human Endostatin Revenue Share by Type (2021-2032) Figure 46. Europe Recombinant Human Endostatin Sales Share by Type (2021-2032) Figure 47. Europe Recombinant Human Endostatin Revenue Share by Application (2021-2032) Figure 48. Europe Recombinant Human Endostatin Sales Share by Application (2021-2032) Figure 49. Europe Recombinant Human Endostatin Revenue Share by Country (2021-2032) Figure 50. Europe Recombinant Human Endostatin Sales Share by Country (2021-2032) Figure 51. China Recombinant Human Endostatin Revenue Share by Type (2021-2032) Figure 52. China Recombinant Human Endostatin Sales Share by Type (2021-2032) Figure 53. China Recombinant Human Endostatin Revenue Share by Application (2021-2032) Figure 54. China Recombinant Human Endostatin Sales Share by Application (2021-2032) Figure 55. Asia Recombinant Human Endostatin Revenue Share by Type (2021-2032) Figure 56. Asia Recombinant Human Endostatin Sales Share by Type (2021-2032) Figure 57. Asia Recombinant Human Endostatin Revenue Share by Application (2021-2032) Figure 58. Asia Recombinant Human Endostatin Sales Share by Application (2021-2032) Figure 59. Asia Recombinant Human Endostatin Revenue Share by Country (2021-2032) Figure 60. Asia Recombinant Human Endostatin Sales Share by Country (2021-2032) Figure 61. SAMEA Recombinant Human Endostatin Revenue Share by Type (2021-2032) Figure 62. SAMEA Recombinant Human Endostatin Sales Share by Type (2021-2032) Figure 63. SAMEA Recombinant Human Endostatin Revenue Share by Application (2021-2032) Figure 64. SAMEA Recombinant Human Endostatin Sales Share by Application (2021-2032) Figure 65. SAMEA Recombinant Human Endostatin Revenue Share by Country (2021-2032) Figure 66. SAMEA Recombinant Human Endostatin Sales Share by Country (2021-2032) Figure 67. Recombinant Human Endostatin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Recombinant Human Endostatin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Purity:95%
  • Others
Applications
  • Medical Care
  • Scientific Research
  • Others
Companies covered
  • Thermo Fisher Scientific
  • PeproTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Human Endostatin Market by Type
  3. 1.2.1 Global Recombinant Human Endostatin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity:95%
  5. 1.2.3 Others
  6. 1.3 Recombinant Human Endostatin Market by Application
  7. 1.3.1 Global Recombinant Human Endostatin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Care
  9. 1.3.3 Scientific Research
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Recombinant Human Endostatin Market Dynamics
  1. 2.1 Recombinant Human Endostatin Industry Trends
  2. 2.2 Recombinant Human Endostatin Industry Drivers
  3. 2.3 Recombinant Human Endostatin Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Endostatin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Human Endostatin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Human Endostatin Revenue by Region
  3. 3.2.1 Global Recombinant Human Endostatin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Human Endostatin Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Human Endostatin Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Human Endostatin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Human Endostatin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Human Endostatin Sales by Region
  9. 3.4.1 Global Recombinant Human Endostatin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Human Endostatin Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Human Endostatin Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Human Endostatin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Human Endostatin Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Human Endostatin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Human Endostatin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Human Endostatin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Human Endostatin Sales by Manufacturers
  6. 4.2.1 Global Recombinant Human Endostatin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Human Endostatin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Human Endostatin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Human Endostatin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Human Endostatin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Human Endostatin Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Human Endostatin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Human Endostatin Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Human Endostatin Tier 1, Tier 2, and Tier 3
5 Recombinant Human Endostatin Market by Type
  1. 5.1 Global Recombinant Human Endostatin Revenue by Type
  2. 5.1.1 Global Recombinant Human Endostatin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Human Endostatin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Human Endostatin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Human Endostatin Sales by Type
  6. 5.2.1 Global Recombinant Human Endostatin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Endostatin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant Human Endostatin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Human Endostatin Price by Type
6 Recombinant Human Endostatin Market by Application
  1. 6.1 Global Recombinant Human Endostatin Revenue by Application
  2. 6.1.1 Global Recombinant Human Endostatin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Human Endostatin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Human Endostatin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Human Endostatin Sales by Application
  6. 6.2.1 Global Recombinant Human Endostatin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Human Endostatin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant Human Endostatin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Human Endostatin Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 PeproTech
  8. 7.2.1 PeproTech Company Information
  9. 7.2.2 PeproTech Business Overview
  10. 7.2.3 PeproTech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 PeproTech Recombinant Human Endostatin Product Portfolio
  12. 7.2.5 PeproTech Recent Developments
8 North America
  1. 8.1 North America Recombinant Human Endostatin Market Size by Type
  2. 8.1.1 North America Recombinant Human Endostatin Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Human Endostatin Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Human Endostatin Price by Type (2021-2032)
  5. 8.2 North America Recombinant Human Endostatin Market Size by Application
  6. 8.2.1 North America Recombinant Human Endostatin Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Human Endostatin Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Human Endostatin Price by Application (2021-2032)
  9. 8.3 North America Recombinant Human Endostatin Market Size by Country
  10. 8.3.1 North America Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Human Endostatin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Human Endostatin Market Size by Type
  2. 9.1.1 Europe Recombinant Human Endostatin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Human Endostatin Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Human Endostatin Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Human Endostatin Market Size by Application
  6. 9.2.1 Europe Recombinant Human Endostatin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Human Endostatin Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Human Endostatin Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Human Endostatin Market Size by Country
  10. 9.3.1 Europe Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Human Endostatin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Human Endostatin Market Size by Type
  2. 10.1.1 China Recombinant Human Endostatin Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Human Endostatin Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Human Endostatin Price by Type (2021-2032)
  5. 10.2 China Recombinant Human Endostatin Market Size by Application
  6. 10.2.1 China Recombinant Human Endostatin Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Human Endostatin Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Human Endostatin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Human Endostatin Market Size by Type
  2. 11.1.1 Asia Recombinant Human Endostatin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Human Endostatin Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Human Endostatin Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Human Endostatin Market Size by Application
  6. 11.2.1 Asia Recombinant Human Endostatin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Human Endostatin Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Human Endostatin Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Human Endostatin Market Size by Country
  10. 11.3.1 Asia Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Human Endostatin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Human Endostatin Market Size by Type
  2. 12.1.1 SAMEA Recombinant Human Endostatin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Human Endostatin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Human Endostatin Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Human Endostatin Market Size by Application
  6. 12.2.1 SAMEA Recombinant Human Endostatin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Human Endostatin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Human Endostatin Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Human Endostatin Market Size by Country
  10. 12.3.1 SAMEA Recombinant Human Endostatin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Human Endostatin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Human Endostatin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Human Endostatin Value Chain Analysis
  2. 13.1.1 Recombinant Human Endostatin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Human Endostatin Production Mode & Process
  6. 13.2 Recombinant Human Endostatin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Human Endostatin Distributors
  9. 13.2.3 Recombinant Human Endostatin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst